The Future of Transfusion Medicine and Biotherapies

We all work so hard for our patients, our donors and our research, so it’s important to take time to recharge, show up for ourselves and support one another. During the 2025 AABB Annual Meeting in San Diego, attendees will have myriad opportunities to celebrate their colleagues' accomplishments, sharpen their knowledge and discuss issues pertinent to the field of transfusion medicine and biotherapies in a safe, collaborative space. The exchange of knowledge within the global community will inspire you, challenge you and spark new ideas.   

This issue of AABB News focuses on the technology that is helping to advance transfusion medicine and biotherapies. In the first feature, researchers explore the practical application of machine learning or other artificial intelligence algorithms being applied to transfusion prediction. The second article examines the impact of virtual reality in transfusion training, highlighting the United Kingdom’s NHS Blood and Transplant’s (NHSBT) innovative blood identification and crossmatching apps. In the third feature, two blood centers discuss the evolution of technology and how artificial intelligence is reshaping donor recruitment strategies.  

In addition, this issue features an interview with Steven Armstrong, DHA, MT(AMT), SBB(ASCP), FACHE, chair of AABB’s Annual Meeting Education Committee. Read the article to learn more about this year's highlights and what attendees can expect from the event, including a very special opening keynote address from Mr. Tom Whitehead, co-founder of the Emily Whitehead Foundation and father of the first pediatric patient to receive CAR T cells for pediatric cancer. Their story is touching and one you don’t want to miss.